Covid-19 + Influenza A/B+RSV Combo Rapid Test

Covid-19 + Influenza A/B + RSV Combo Rapid Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A (including the subtype H1N1), influenza B and respiratory syncytial virus in nasopharyngeal swab or nasal swab specimens from symptomatic and asymptomatic patients. It is intended to aid in the rapid diagnosis of SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus infections in the healthcare setting management, general population screening, workplace screening, etc. It is intended to be used by a trained healthcare professional, member of the allied health professions, and trained lay-person at point-of-care, near-patient, and laboratory-based testing.

This test provides only a preliminary test result. Therefore, any reactive specimen with the Covid-19 + Influenza A/B+RSV Combo Rapid Test must be confirmed with alternative testing method(s) and clinical findings.